Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis

Hayakawa, Naoki; Kodera, Satoshi; Takanashi, Keisuke; Kanagami, Teruaki; Ichihara, Shinya; Arakawa, Masataka; Hirano, Seishiro; Inoguchi, Yasunori; Shakya, Sandeep; Kanda, Junji

doi:10.1016/j.carrev.2022.04.002

Cited by 4 publications

(5 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Roberts highlighted a 6.1% complication rate, demonstrating safety in bleeding ruptured VAPs [ 66 ]. Furthermore, the safety results of our report, including vascular access site complications, align with previous studies conducted on endovascular treatments and transcatheter arterial embolization [ 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 ]. Finally, this retrospective multicenter study provides further evidence supporting the safety and efficacy of endovascular embolization using EVOH copolymer-based non-adhesive liquid embolic agents (NALEAs) for the management of visceral pseudoaneurysms.…”

Section: Discussionsupporting

confidence: 88%

Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs)

Minici,

Guerriero,

Fontana

et al. 2023

Medicina

View full text Add to dashboard Cite

Background and Objectives: Treatment of visceral artery pseudoaneurysms (VAPs) is always indicated regardless of their diameters, as their risk of rupture is significantly higher than that of visceral artery aneurysms. The invasiveness of surgery and its associated complications have led to a shift in favor of radiological interventions as the initial treatment of choice. However, there are still some unanswered questions on endovascular treatment of VAPs regarding the optimal endovascular technique and the efficacy and safety outcomes. The purpose of this multicenter study was to retrospectively evaluate the effectiveness and safety of endovascular treatment of visceral pseudoaneurysms using Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs). Materials and Methods: Consecutive patients who underwent endovascular embolization with EVOH-based NALEAs for visceral artery pseudoaneurysms between January 2018 and June 2023 were retrospectively evaluated. Results: 38 embolizations were performed. Technical success was achieved in all patients. The clinical success rate was high (92.1% overall), with no significant differences between ruptured and unruptured VAPs (p = 0.679). Seven patients (18.4%) experienced procedure-related complications, related to one case of non-target embolization, four splenic abscesses due to end-organ infarction, and two femoral pseudoaneurysms. The rates of procedure-related complications, end-organ infarction, and vascular access-site complications did not significantly differ between ruptured and unruptured VAPs (p > 0.05). Conclusions: Both ruptured and unruptured visceral pseudoaneurysms can be effectively and safely treated with NALEA-based endovascular embolization. We suggest considering the use of NALEAs, particularly in specific clinical cases that highlight their advantages, including patients with coagulopathy, fragile vessels, and embolization targets that are located at a considerable distance from the microcatheter tip and are otherwise difficult to reach.

show abstract

Section: Discussionsupporting

confidence: 88%

Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs)

Minici,

Guerriero,

Fontana

et al. 2023

Medicina

View full text Add to dashboard Cite

show abstract

“…Endovascular recanalization is increasingly used as the initial revascularization strategy for the arterial occlusive disease of the femoro-popliteal district. [1][2][3][4][5][6][7][8] Antegrade crossing of femoro-popliteal occlusions may fail in about 20%-25% of cases, even in high volume centres with experienced operators and despite the development in endovascular technologies and the introduction of new tools in clinical practice such as re-entry devices. 5,[9][10][11]31,32 In cases of failure of the antegrade approach, crossing the lesion in a retrograde fashion represents a safe and effective alternative.…”

Section: Discussionmentioning

confidence: 99%

“…Endovascular recanalization is increasingly used as the initial revascularization strategy for the arterial occlusive disease of the femoro-popliteal district. [1][2][3][4][5][6][7][8] The standard route for the treatment of femoro-popliteal arterial disease is the anterograde approach via the common femoral artery, because of its large diameter and unique anatomical location. Despite the development in endovascular technologies and the introduction of new tools in clinical practice, 5 the endovascular crossing of femoro-popliteal occlusions is not always possible with the antegrade approach, especially in long chronic occlusions, heavily calcified lesions or when the femoral artery is inaccessible.…”

Section: Introductionmentioning

confidence: 99%

“…Endovascular recanalization is increasingly used as the initial revascularization strategy for the arterial occlusive disease of the femoro‐popliteal district 1–8 . The standard route for the treatment of femoro‐popliteal arterial disease is the anterograde approach via the common femoral artery, because of its large diameter and unique anatomical location.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Endovascular treatment of femoro‐popliteal occlusions with retrograde tibial access after failure of the antegrade approach

Minici

Serra

Rosi

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

Background: Despite the development in endovascular technologies and the introduction of new tools in clinical practice, the endovascular crossing of femoropopliteal occlusions is not always possible with the antegrade approach, with a failure rate that can be up to 20%. This study aims to assess the feasibility, safety, and efficacy in terms of acute outcome of the endovascular retrograde crossing of femoro-popliteal occlusions with tibial access.Methods: This study is a single-centre, retrospective analysis of prospectively collected data of 152 consecutive patients, who had undergone, from September 2015 to September 2022, endovascular treatment of femoro-popliteal arterial occlusions with retrograde tibial access after the failure of the antegrade approach.Results: The median lesion length was 25 cm and 66 patients (43.4%) had a calcium grading according to the peripheral arterial calcium scoring system of 4. Angiographically, 44.7% of the lesions were TASC II category D. In all cases, successful cannulation and sheath introduction were performed with an average cannulation time of 150.4 s. Femoropopliteal occlusions were successfully crossed with the retrograde route in 94.1% of cases; the intimal approach was performed in 114 patients (79.7%). The mean time from puncture to retrograde crossing was 20.5 min. Acute vascular access-site complications were noted in 7 (4.6%) patients.Thirty-day major adverse cardiovascular events rate and 30-day major adverse limb events rate of 3.3% and 2%, respectively, were observed. Conclusions:The results of our study indicate that retrograde crossing of femoropopliteal occlusions with tibial access is a feasible, effective, and safe approach in case of failed antegrade approach. The results presented represent one of the

show abstract

“…Lastly, no significantly different results were achieved using paclitaxel-based drug-eluting stents (DES) compared to bare metal stents [77]. Moreover, high-dose DCB, after a successful vessel preparation, showed comparable rates with DES in terms of freedom from target lesion revascularization [78]. Over time, because of controversial findings regarding the safety of paclitaxel-based DCBs [79,80], the development of devices led to the introduction of Sirolimus as a new coating antiproliferative drug.…”

Section: Surgical and Endovascular Managementmentioning

confidence: 99%

The Ability to Look Beyond: The Treatment of Peripheral Arterial Disease

Sirignano

Margheritini

Ruggiero

et al. 2023

JCM

View full text Add to dashboard Cite

This paper offers a practical overview of the contemporary management of patients with peripheral arterial disease presenting intermittent claudication (IC), including clinical and instrumental diagnosis, risk factors modification, medical management, and evidence-based revascularization indications and techniques. Decision making represents a crucial element in the management of the patient with IC; for this, we think a review of this type could be very useful, especially for non-vascular specialists.

show abstract

Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis

Cited by 4 publications

References 28 publications

Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs)

Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs)

Endovascular treatment of femoro‐popliteal occlusions with retrograde tibial access after failure of the antegrade approach

The Ability to Look Beyond: The Treatment of Peripheral Arterial Disease

Contact Info

Product

Resources

About